Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes

Elena Viganò(Agency for Science, Technology and Research), Catherine Emma Diamond(Agency for Science, Technology and Research), Roberto Spreafico(Agency for Science, Technology and Research), Akhila Balachander(Agency for Science, Technology and Research), Radoslaw M. Sobota(Agency for Science, Technology and Research), Alessandra Mortellaro(Agency for Science, Technology and Research)
Nature Communications
October 28, 2015
Cited by 340Open Access
Full Text

Abstract

Monocytes promote the early host response to infection releasing key pro-inflammatory cytokines, such as IL-1β. The biologically inactive IL-1β precursor is processed to active form by inflammasomes, multi-protein complexes activating caspase-1. Human monocytes exhibit an unconventional one-step pathway of inflammasome activation in response to lipopolysaccharide (LPS) alone. Although this lineage-restricted mechanism is likely to contribute to the pathology of endotoxin shock, signalling pathways regulating this mechanism are currently unknown. Here we report that caspase-4 and caspase-5 mediate IL-1α and IL-1β release from human monocytes after LPS stimulation. Although caspase-4 remains uncleaved, caspase-5 undergoes rapid processing upon LPS treatment. We also identify an additional caspase-5 cleavage product in LPS-stimulated monocytes, which correlates with IL-1 secretion. This one-step pathway requires Syk activity and Ca(2+) flux instigated by CD14/TLR4-mediated LPS internalization. Identification of caspase-4/5 as the key determinants of one-step inflammasome activation in human monocytes provides potential targets for therapeutic intervention in endotoxin shock.


Related Papers

No related papers found

Powered by citation graph analysis